HDAC2 and chronic obstructive pulmonary disease: When we analyzed the COPD patients according to disease severity (mild, moderate, severe, and very severe), based on lung function by the spirometry test, a significant reduction of the EP300 gene expression was observed in severe COPD patients (Figure 1e), and a notable HDAC2 reduction in mild, moderate, and severe COPD patients (Figure 1f).